Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term Follow-Up Studies. Found 80 abstracts

no pagination
Haas NB, Manola J, Dutcher JP, Flaherty KT, Uzzo RG, Atkins MB, DiPaola RS, Choueiri TK. Adjuvant Treatment for High-Risk Clear Cell Renal Cancer: Updated Results of a High-Risk Subset of the ASSURE Randomized Trial. JAMA Oncol. 2017 Sep;3(9):1249-52.   PMCID: PMC5591751
Heckman CJ, Handorf EA, Darlow SD, Ritterband LM, Manne SL. An online skin cancer risk-reduction intervention for young adults: Mechanisms of effects. Health Psychol. 2017 Mar;36(3):215-25.   PMCID: PMC5328853
Hellmann MD, Rizvi NA, Goldman JW, Gettinger SN, Borghaei H, Brahmer JR, Ready NE, Gerber DE, Chow LQ, Juergens RA, Shepherd FA, Laurie SA, Geese WJ, Agrawal S, Young TC, Li X, Antonia SJ. Nivolumab plus ipilimumab as first-line treatment for advanced non-small-cell lung cancer (CheckMate 012): results of an open-label, phase 1, multicohort study. Lancet Oncol. 2017 Jan;18(1):31-41.   PMCID: PMC5476941
Lawton CA, Lin X, Hanks GE, Lepor H, Grignon DJ, Brereton HD, Bedi M, Rosenthal SA, Zeitzer KL, Venkatesan VM, Horwitz EM, Pisansky TM, Kim H, Parliament MB, Rabinovitch R, Roach M, Kwok Y, Dignam JJ, Sandler HM. Duration of Androgen Deprivation in Locally Advanced Prostate Cancer: Long-Term Update of NRG Oncology RTOG 9202. Int J Radiat Oncol Biol Phys. 2017 Jun;98(2):296-303.   PMCID: PMC5603177
Pollack A, Kwon D, Walker G, Khor LY, Horwitz EM, Buyyounouski MK, Stoyanova R. Prospective Validation of Diagnostic Tumor Biomarkers in Men Treated With Radiotherapy for Prostate Cancer. Journal of the National Cancer Institute. 2017 Feb;109(2):1-8.
Sanchorawala V, Palladini G, Kukreti V, Zonder JA, Cohen AD, Seldin DC, Dispenzieri A, Jaccard A, Schonland SO, Berg D, Yang H, Gupta N, Hui AM, Comenzo RL, Merlini G. A phase 1/2 study of the oral proteasome inhibitor ixazomib in relapsed or refractory AL amyloidosis. Blood. 2017 Aug 03;130(5):597-605.
Wang LS, Handorf EA, Wu H, Liu JC, Perlis CS, Galloway TJ. Surgery and Adjuvant Radiation for High-risk Skin Adnexal Carcinoma of the Head and Neck. Am J Clin Oncol. 2017 Aug;40(4):429-32.   PMCID: PMC4504824
Guttmann DM, Li H, Sevak P, Grover S, Jacobson G, Feldman A, Rubin S, Chu C, Bhatia S, Elshaikh MA, Lin LL. The Impact of Adjuvant Therapy on Survival and Recurrence Patterns in Women With Early-Stage Uterine Carcinosarcoma: A Multi-institutional Study. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society. 2016 Jan;26(1):141-8.
Hossain NM, Klumpp T, Ulicny J, Garner M, Kropf PL, Mangan KF, Barta SK, Fung HC, Martin ME. Donor Lymphocyte Infusion in Hematologic Malignancies--Good to be Fresh?. Clinical lymphoma, myeloma & leukemia. 2016 Feb;16(2):111-5.
Meropol NJ, Wong YN, Albrecht T, Manne S, Miller SM, Flamm AL, Benson AB, Buzaglo J, Collins M, Egleston B, Fleisher L, Katz M, Kinzy TG, Liu TM, Margevicius S, Miller DM, Poole D, Roach N, Ross E, Schluchter MD. Randomized Trial of a Web-Based Intervention to Address Barriers to Clinical Trials. J Clin Oncol. 2016 Feb 10;34(5):469-78.   PMCID: PMC4872012
Wang M, Devarajan K, Singal AG, Marrero JA, Dai J, Feng Z, Rinaudo JA, Srivastava S, Evans A, Hann HW, Lai Y, Yang H, Block TM, Mehta A. The Doylestown Algorithm: A Test to Improve the Performance of AFP in the Detection of Hepatocellular Carcinoma. Cancer prevention research (Philadelphia, Pa). 2016 Feb;9(2):172-9.   PMCID: PMC4740237
Balamucki CJ, DeJesus R, Galloway TJ, Mancuso AA, Amdur RJ, Morris CG, Kirwan JM, Mendenhall WM. Impact of radiographic findings on for prognosis skin cancer with perineural invasion. Am J Clin Oncol. 2015 Jun;38(3):248-51.
Chen KT, Devarajan K, Hoffman JP. Morbidity among long-term survivors after pancreatoduodenectomy for pancreatic adenocarcinoma. Ann Surg Oncol. 2015 Apr;22(4):1185-9.
Dabaja BS, Vanderplas AM, Crosby-Thompson AL, Abel GA, Czuczman MS, Friedberg JW, Gordon LI, Kaminski M, Niland J, Millenson M, Nademanee AP, Zelenetz A, LaCasce AS, Rodriguez MA. Radiation for diffuse large B-cell lymphoma in the rituximab era: analysis of the National Comprehensive Cancer Network lymphoma outcomes project. Cancer. 2015 Apr;121(7):1032-9.
Foy JP, Pickering CR, Papadimitrakopoulou VA, Jelinek J, Lin SH, William WN, Frederick MJ, Wang J, Lang W, Feng L, Zhang L, Kim ES, Fan YH, Hong WK, El-Naggar AK, Lee JJ, Myers JN, Issa JP, Lippman SM, Mao L, Saintigny P. New DNA Methylation Markers and Global DNA Hypomethylation Are Associated with Oral Cancer Development. Cancer prevention research (Philadelphia, Pa). 2015 Nov;8(11):1027-35.   PMCID: 4777304
Hodge MG, Hovinga M, Shepherd JA, Egleston B, Gabriel K, Van Horn L, Robson A, Snetselaar L, Stevens VK, Jung S, Dorgan J. Youth and young adult physical activity and body composition of young adult women: findings from the dietary intervention study in children. Pediatr Exerc Sci. 2015 Feb;27(1):140-50.
Siminoff LA, Molisani AJ, Traino HM. A Comparison of the Request Process and Outcomes in Adult and Pediatric Organ Donation. Pediatrics. 2015 Jul;136(1):e108-e114.   PMCID: 4485007
Sweeney CJ, Chen YH, Carducci M, Liu G, Jarrard DF, Eisenberger M, Wong YN, Hahn N, Kohli M, Cooney MM, Dreicer R, Vogelzang NJ, Picus J, Shevrin D, Hussain M, Garcia JA, DiPaola RS. Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer. The New England journal of medicine. 2015 Aug 20;373(8):737-46.   PMCID: 4562797
Tomaszewski JJ, Uzzo RG, Egleston B, Corcoran AT, Mehrazin R, Geynisman DM, Ridge JA, Veloski C, Kocher N, Smaldone MC, Kutikov A. Coupling of Prostate and Thyroid Cancer Diagnoses in the United States. Annals of Surgical Oncology. 2015 Mar;22(3):1043-9.   PMCID: 4419700
Brana I, Berger R, Golan T, Haluska P, Edenfield J, Fiorica J, Stephenson J, Martin LP, Westin S, Hanjani P, Jones MB, Almhanna K, Wenham RM, Sullivan DM, Dalton WS, Gunchenko A, Cheng JD, Siu LL, Gray JE. A parallel-arm phase I trial of the humanised anti-IGF-1R antibody dalotuzumab in combination with the AKT inhibitor MK-2206, the mTOR inhibitor ridaforolimus, or the NOTCH inhibitor MK-0752, in patients with advanced solid tumours. Br J Cancer. 2014 Nov 11;111(10):1932-44.   PMCID: Pmc4229637
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term Follow-Up Studies

Follow-Up Studies Male Female Middle Aged Aged pathology Prognosis Adult therapeutic use Neoplasm Staging mortality drug therapy Survival Rate Disease-Free Survival 80 and over Aged Prospective Studies administration & dosage adverse effects methods therapy Combined Modality Therapy Local Neoplasm Recurrence blood Prostatic Neoplasms Antineoplastic Combined Chemotherapy Protocols surgery Cohort Studies analogs & derivatives Adenocarcinoma Retrospective Studies Prostate-Specific Antigen Androgen Antagonists Surveys and Questionnaires Squamous Cell Carcinoma Dose Fractionation Head and Neck Neoplasms Neoplasm Invasiveness Decision Making Monoclonal Antibodies analysis Internet radiotherapy psychology Child prevention & control Adjuvant Radiotherapy diagnosis Adjuvant Chemotherapy Tumor Biomarkers Antineoplastic Agents Skin Neoplasms Tissue Donors Young Adult Risk Factors epidemiology ROC Curve Case-Control Studies United States Neoplasms Ki-67 Antigen Immunoenzyme Techniques DNA Methylation Chemoradiotherapy Exercise Disease Progression Health Communication Phenylurea Compounds Area Under Curve Self Efficacy Flutamide radiography IGF Type 1 Receptor Cell Line Persistent or relapsed disease Non-Small-Cell Lung Carcinoma Attitudes Health Knowledge-Practice SEER Program Clinical Trials as Topic Event-free survival consolidation Magnetic Resonance Imaging Proportional Hazards Models Pancreatic Neoplasms Hematopoietic Stem Cell Transplantation Taxoids Hematologic Neoplasms Liver Neoplasms Incidence Propionates Liver Cirrhosis Proto-Oncogene Proteins c-bcl-2 Survivors Lymphocyte Transfusion Pyrroles Randomized Controlled Trials as Topic genetics Patient Education as Topic Adnexal and Skin Appendage Neoplasms Treatment Outcome Amyloidosis Prednisone doxorubicin alpha-Fetoproteins Radiotherapy Dosage Algorithms TOR Serine-Threonine Kinases Phase III Clinical Trials as Topic Oral Administration Double-Blind Method Hysterectomy statistics & numerical data Hepatocellular Carcinoma Combination Drug Therapy Kidney Neoplasms Peripheral Nerves Sulfones Adolescent Early Intervention (Education) Rituximab CpG Islands Neutropenia Glycine Mouth Neoplasms National Cancer Institute (US) Postoperative Complications Intention Monoclonal Antibodies-Murine-Derived DNA Sequence Analysis Proteasome Inhibitors Morbidity chemically induced Treatment Failure Goserelin physiology Cyclin-Dependent Kinase Inhibitor p16 Genetic Promoter Regions chemistry Angiotensin Receptor-Type 1 Large B-Cell Lymphoma-Diffuse pharmacokinetics Doxorubicin Vincristine Pancreaticoduodenectomy Biological Tumor Markers Photon Absorptiometry Notch Receptors secondary radiation utilization Second Primary Neoplasms
Last updated on Tuesday, October 10, 2017